948
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Why are so few antipsychotic drugs licensed for Alzheimer’s disease related behavioral and psychological symptoms?

, &
Pages 1051-1053 | Received 02 Mar 2019, Accepted 05 Jul 2019, Published online: 15 Jul 2019

References

  • International, A.s.D. World Alzheimer report 2018. 2018.
  • Caspar S, Davis ED, Douziech A, et al. Nonpharmacological management of behavioral and psychological symptoms of dementia: what works, in what circumstances, and why? Innovation Aging. 2017;1(3).
  • Abraha I, Rimland JM, Trotta FM, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. Bmj Open. 2017;7(3):e012759.
  • Berrios GE. The insanities of the third age: a conceptual history of paraphrenia. J Nutr Health Aging. 2003;7(6):394–399.
  • Hafner H, Hambrecht M, Löffler W, et al. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol Med. 1998;28(2):351–365.
  • Murray PS, Kumar S, Demichele-Sweet MAA, et al. Psychosis in Alzheimer’s disease. Biol Psychiatry. 2014;75(7):542–552.
  • Brendel RW, Stern TA. Psychotic symptoms in the elderly. Prim Care Companion J Clin Psychiatry. 2005;7(5):238–241.
  • El Haj M, Roche J, Jardri R, et al. Clinical and neurocognitive aspects of hallucinations in Alzheimer’s disease. Neurosci Biobehav Rev. 2017;83:713–720.
  • Lanctôt KL, Amatniek J, Ancoli-Israel S, et al. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms. Alzheimers Dement (N Y). 2017;3(3):440–449.
  • Reeves SJ, Gould RL, Powell JF, et al. Origins of delusions in Alzheimer’s disease. Neurosci Biobehav Rev. 2012;36(10):2274–2287.
  • Ballard C, Howard R. Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci. 2006;7(6):492–500.
  • Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med. 2006;355(15):1525–1538.
  • Creese B, Da Silva MV, Johar I, et al. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer’s disease. Expert Rev Neurother. 2018;18(6):461–467.
  • Murray PS, Kumar S, Demichele-Sweet MAA, et al. Psychosis in Alzheimer’s disease. Biol Psychiatry. 2014;75(7):542–552.
  • Monzani F, Pasqualetti G, Tognini S, et al. Potential drug–drug interactions in Alzheimer patients with behavioral symptoms. Clin Interv Aging. 2015;10:1457-1466.
  • Ahmed M, Malik M, Teselink J, et al. Current agents in development for treating behavioral and psychological symptoms associated with Dementia. Drugs Aging. 2019;36:589–605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.